ICARES Medicus, Inc. (TPEX:6612)
Taiwan · Delayed Price · Currency is TWD 70.20
+1.10 (1.59%)
At close: Mar 27, 2026
ICARES Medicus Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 51.23 | 103.12 | 97.73 | 128.91 | 58.6 |
Depreciation & Amortization | 144.81 | 87.52 | 42.66 | 26.56 | 27.16 |
Other Amortization | 4.95 | 1.53 | 1.08 | 1.75 | 1.54 |
Loss (Gain) From Sale of Assets | 0.03 | 0.95 | - | - | - |
Loss (Gain) From Sale of Investments | 9.35 | -0.57 | -8.87 | -4.67 | 13.12 |
Loss (Gain) on Equity Investments | -3.66 | -2.38 | 1.35 | 4.18 | 2.17 |
Stock-Based Compensation | 26.25 | 27.39 | 20.13 | 9.79 | 11.13 |
Provision & Write-off of Bad Debts | -0.16 | 5.81 | 10.08 | 2.43 | 3.16 |
Other Operating Activities | -86.51 | -10.14 | -38.05 | -24.64 | -29.33 |
Change in Accounts Receivable | -94.79 | -11.49 | -33.28 | -45.69 | -28.04 |
Change in Inventory | -82.57 | -115.21 | -50.33 | -20.82 | -9.49 |
Change in Accounts Payable | 9.59 | -19.74 | -1.76 | 3.67 | 0.89 |
Change in Unearned Revenue | 2.87 | -7.55 | 5.31 | - | - |
Change in Other Net Operating Assets | -40.22 | -107.74 | -71.83 | 47.44 | -12.33 |
Operating Cash Flow | -58.83 | -48.52 | -25.79 | 128.92 | 38.57 |
Operating Cash Flow Growth | - | - | - | 234.27% | -45.96% |
Capital Expenditures | -49.52 | -148.97 | -70.95 | -31.45 | -5.39 |
Sale of Property, Plant & Equipment | 0.1 | 1.39 | - | - | 0.01 |
Cash Acquisitions | - | -688.43 | - | - | - |
Sale (Purchase) of Intangibles | -3.96 | -7.75 | -5.52 | -2.59 | -1.09 |
Investment in Securities | 3.59 | -6.68 | -449.46 | -167.07 | - |
Other Investing Activities | -40.93 | 292.66 | -1.65 | -1.45 | -0.13 |
Investing Cash Flow | -90.71 | -557.79 | -527.58 | -202.56 | -6.6 |
Short-Term Debt Issued | 256.66 | 338.83 | 21.49 | - | - |
Long-Term Debt Issued | 0.45 | 505.44 | - | - | - |
Total Debt Issued | 257.12 | 844.27 | 21.49 | - | - |
Long-Term Debt Repaid | -278.97 | -177.99 | -18.03 | -8.29 | -8.12 |
Total Debt Repaid | -278.97 | -177.99 | -18.03 | -8.29 | -8.12 |
Net Debt Issued (Repaid) | -21.85 | 666.28 | 3.46 | -8.29 | -8.12 |
Issuance of Common Stock | 59.71 | - | 598.43 | - | - |
Common Dividends Paid | -12.92 | -7.83 | -34.16 | -16.99 | -3.4 |
Other Financing Activities | 153.99 | -0.94 | 88.37 | 1.38 | 58.09 |
Financing Cash Flow | 178.92 | 657.51 | 656.1 | -23.89 | 46.57 |
Foreign Exchange Rate Adjustments | -10.07 | 7.32 | -6.05 | 25.86 | -3.62 |
Net Cash Flow | 19.3 | 58.52 | 96.67 | -71.67 | 74.92 |
Free Cash Flow | -108.35 | -197.49 | -96.74 | 97.47 | 33.18 |
Free Cash Flow Growth | - | - | - | 193.75% | -46.70% |
Free Cash Flow Margin | -9.58% | -22.97% | -15.98% | 19.04% | 8.42% |
Free Cash Flow Per Share | -2.29 | -4.18 | -2.28 | 2.37 | 0.81 |
Cash Interest Paid | 23.25 | 17.86 | 6.79 | 0.35 | 0.62 |
Cash Income Tax Paid | 103.32 | 72.17 | 54.77 | 40.74 | 42.44 |
Levered Free Cash Flow | -37.44 | -286.65 | -43.38 | 10.56 | 96.64 |
Unlevered Free Cash Flow | -22.32 | -275.19 | -38.89 | 10.92 | 97.16 |
Change in Working Capital | -205.12 | -261.74 | -151.89 | -15.4 | -48.98 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.